35053241|t|The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson's Disease.
35053241|a|Parkinson's disease (PD) is a neurodegenerative disease incurable due to late diagnosis and treatment. Therefore, one of the priorities of neurology is to study the mechanisms of PD pathogenesis at the preclinical and early clinical stages. Given the important role of sphingolipids in the pathogenesis of neurodegenerative diseases, we aimed to analyze the gene expression of key sphingolipid metabolism enzymes (ASAH1, ASAH2, CERS1, CERS3, CERS5, GBA1, SMPD1, SMPD2, UGCG) and the content of 32 sphingolipids (subspecies of ceramides, sphingomyelins, monohexosylceramides and sphinganine, sphingosine, and sphingosine-1-phosphate) in the nigrostriatal system in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models of the preclinical and clinical stages of PD. It has been shown that in PD models, the expression of five of the nine studied genes (CERS1, CERS5, ASAH1, ASAH2, and GBA1) increases but only in the substantia nigra (SN) containing dopaminergic cell bodies. Changes in the expression of enzyme genes were accompanied by an increase in the content of 7 of the 32 studied sphingolipids. Such findings suggest these genes as attractive candidates for diagnostic purposes for preclinical and clinical stages of PD.
35053241	4	16	Sphingolipid	Chemical	MESH:D013107
35053241	65	69	Mice	Species	10090
35053241	80	99	Parkinson's Disease	Disease	MESH:D010300
35053241	101	120	Parkinson's disease	Disease	MESH:D010300
35053241	122	124	PD	Disease	MESH:D010300
35053241	131	156	neurodegenerative disease	Disease	MESH:D019636
35053241	280	282	PD	Disease	MESH:D010300
35053241	370	383	sphingolipids	Chemical	MESH:D013107
35053241	407	433	neurodegenerative diseases	Disease	MESH:D019636
35053241	482	494	sphingolipid	Chemical	MESH:D013107
35053241	515	520	ASAH1	Gene	11886
35053241	522	527	ASAH2	Gene	54447
35053241	529	534	CERS1	Gene	93898
35053241	536	541	CERS3	Gene	545975
35053241	543	548	CERS5	Gene	71949
35053241	550	554	GBA1	Gene	14466
35053241	556	561	SMPD1	Gene	20597
35053241	563	568	SMPD2	Gene	20598
35053241	570	574	UGCG	Gene	22234
35053241	598	611	sphingolipids	Chemical	MESH:D013107
35053241	627	636	ceramides	Chemical	MESH:D002518
35053241	638	652	sphingomyelins	Chemical	MESH:D013109
35053241	654	674	monohexosylceramides	Chemical	MESH:C013870
35053241	679	690	sphinganine	Chemical	MESH:C005682
35053241	692	703	sphingosine	Chemical	MESH:D013110
35053241	709	732	sphingosine-1-phosphate	Chemical	MESH:C060506
35053241	765	809	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
35053241	811	815	MPTP	Chemical	MESH:D015632
35053241	817	822	mouse	Species	10090
35053241	872	874	PD	Disease	MESH:D010300
35053241	902	904	PD	Disease	MESH:D010300
35053241	963	968	CERS1	Gene	93898
35053241	970	975	CERS5	Gene	71949
35053241	977	982	ASAH1	Gene	11886
35053241	984	989	ASAH2	Gene	54447
35053241	995	999	GBA1	Gene	14466
35053241	1198	1211	sphingolipids	Chemical	MESH:D013107
35053241	1335	1337	PD	Disease	MESH:D010300
35053241	Association	MESH:D013107	545975
35053241	Association	MESH:D010300	93898
35053241	Association	MESH:D010300	54447
35053241	Association	MESH:D013107	71949
35053241	Association	MESH:D013107	MESH:D019636
35053241	Association	MESH:D013107	14466
35053241	Association	MESH:D013107	54447
35053241	Association	MESH:D013107	20597
35053241	Association	MESH:D010300	71949
35053241	Association	MESH:D013107	11886
35053241	Association	MESH:D010300	14466
35053241	Association	MESH:D013107	20598
35053241	Association	MESH:D013107	93898
35053241	Negative_Correlation	MESH:D015632	MESH:D010300
35053241	Association	MESH:D013107	22234
35053241	Association	MESH:D013107	MESH:D010300
35053241	Association	MESH:D010300	11886

